Your browser doesn't support javascript.
loading
Co-expression of tumor antigen and interleukin-2 from an adenoviral vector augments the efficiency of therapeutic tumor vaccination.
Jensen, Benjamin Anderschou Holbech; Steffensen, Maria Abildgaard; Nielsen, Karen Nørgaard; Christensen, Jan Pravsgaard; Thomsen, Allan Randrup; Holst, Peter Johannes.
Afiliación
  • Jensen BAH; Department of International Health, Immunology and Microbiology, University of Copenhagen, Faculty of Health and Medical Sciences, Copenhagen, Denmark; Current addresses: Department of Biology, Faculty of Science, University of Copenhagen, Laboratory for Genomics and Molecular Biomedicine, Copenhage
  • Steffensen MA; Department of International Health, Immunology and Microbiology, University of Copenhagen, Faculty of Health and Medical Sciences, Copenhagen, Denmark.
  • Nielsen KN; Department of International Health, Immunology and Microbiology, University of Copenhagen, Faculty of Health and Medical Sciences, Copenhagen, Denmark; Novo Nordisk, Copenhagen, Denmark.
  • Christensen JP; Department of International Health, Immunology and Microbiology, University of Copenhagen, Faculty of Health and Medical Sciences, Copenhagen, Denmark.
  • Thomsen AR; Department of International Health, Immunology and Microbiology, University of Copenhagen, Faculty of Health and Medical Sciences, Copenhagen, Denmark. Electronic address: athomsen@sund.ku.dk.
  • Holst PJ; Department of International Health, Immunology and Microbiology, University of Copenhagen, Faculty of Health and Medical Sciences, Copenhagen, Denmark; Department of International Health, Immunology and Microbiology, Faculty of Health and Medical Sciences, University of Copenhagen, Laboratory for Ex
Mol Ther ; 22(12): 2107-2117, 2014 Dec.
Article en En | MEDLINE | ID: mdl-25023330

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Cutáneas / Melanoma Experimental / Interleucina-2 / Linfocitos T CD8-positivos / Vectores Genéticos / Antígenos Virales de Tumores Tipo de estudio: Prognostic_studies Límite: Animals Idioma: En Revista: Mol Ther Asunto de la revista: BIOLOGIA MOLECULAR / TERAPEUTICA Año: 2014 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Cutáneas / Melanoma Experimental / Interleucina-2 / Linfocitos T CD8-positivos / Vectores Genéticos / Antígenos Virales de Tumores Tipo de estudio: Prognostic_studies Límite: Animals Idioma: En Revista: Mol Ther Asunto de la revista: BIOLOGIA MOLECULAR / TERAPEUTICA Año: 2014 Tipo del documento: Article